248 related articles for article (PubMed ID: 22887820)
1. Resolute and Xience V polymer-based drug-eluting stents compared in an atherosclerotic rabbit double injury model.
Van Dyck CJ; Hoymans VY; Bult H; Fransen E; Haine S; Bosmans JM; Timmermans JP; Vrints CJ
Catheter Cardiovasc Interv; 2013 Jun; 81(7):E259-68. PubMed ID: 22887820
[TBL] [Abstract][Full Text] [Related]
2. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis.
Hoymans VY; VAN Dyck CJ; Haine SE; Frederix G; Fransen E; Timmermans JP; Vrints CJ
J Interv Cardiol; 2014 Aug; 27(4):381-90. PubMed ID: 24815761
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries.
Torii S; Nakazawa G; Ijichi T; Yoshikawa A; Ohno Y; Ikari Y
Cardiovasc Interv Ther; 2018 Jan; 33(1):55-61. PubMed ID: 27822890
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents.
Yazdani SK; Sheehy A; Nakano M; Nakazawa G; Vorpahl M; Otsuka F; Donn RS; Perkins LE; Simonton CA; Kolodgie FD; Virmani R
J Invasive Cardiol; 2013 Aug; 25(8):383-90. PubMed ID: 23913602
[TBL] [Abstract][Full Text] [Related]
5. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
[TBL] [Abstract][Full Text] [Related]
6. Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome.
Sen H; Lam MK; Tandjung K; Löwik MM; Stoel MG; de Man FH; Louwerenburg JH; van Houwelingen GK; Linssen GC; Doggen CJ; Basalus MW; von Birgelen C
Catheter Cardiovasc Interv; 2015 Jan; 85(1):74-81. PubMed ID: 24585502
[TBL] [Abstract][Full Text] [Related]
7. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
[TBL] [Abstract][Full Text] [Related]
9. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
[TBL] [Abstract][Full Text] [Related]
10. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents.
Mori H; Cheng Q; Lutter C; Smith S; Guo L; Kutyna M; Torii S; Harari E; Acampado E; Joner M; Kolodgie FD; Virmani R; Finn AV
JACC Cardiovasc Interv; 2017 Dec; 10(23):2375-2387. PubMed ID: 29102583
[TBL] [Abstract][Full Text] [Related]
12. Fracture in drug-eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery.
Conway C; Desany GJ; Bailey LR; Keating JH; Baker BL; Edelman ER
Catheter Cardiovasc Interv; 2019 Feb; 93(2):278-285. PubMed ID: 30244502
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.
Tandjung K; Sen H; Lam MK; Basalus MWZ; Louwerenburg JHW; Stoel MG; van Houwelingen KG; de Man FHAF; Linssen GCM; Saïd SAM; Nienhuis MB; Löwik MM; Verhorst PMJ; van der Palen J; von Birgelen C
J Am Coll Cardiol; 2013 Jun; 61(24):2406-2416. PubMed ID: 23602769
[TBL] [Abstract][Full Text] [Related]
14. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).
Lee JM; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Bae JW; Woo SI; Park JS; Jin DK; Jeon DW; Oh SK; Park JS; Kim DI; Hyon MS; Jeon HK; Lim DS; Kim MG; Rha SW; Her SH; Hwang JY; Kim S; Choi YJ; Kang JH; Moon KW; Jang Y; Kim HS
Am J Cardiol; 2014 Nov; 114(9):1329-38. PubMed ID: 25217457
[TBL] [Abstract][Full Text] [Related]
15. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries.
Park KW; Lee JM; Kang SH; Ahn HS; Yang HM; Lee HY; Kang HJ; Koo BK; Cho J; Gwon HC; Lee SY; Chae IH; Youn TJ; Chae JK; Han KR; Yu CW; Kim HS
J Am Coll Cardiol; 2013 Feb; 61(5):536-44. PubMed ID: 23273394
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.
Masawa T; Abe S; Toyoda S; Sakuma M; Nasuno T; Kageyama M; Tokura M; Koizumi S; Taguchi I; Inoue T
Heart Vessels; 2016 Aug; 31(8):1230-8. PubMed ID: 26271923
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
19. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
20. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.
Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK
Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]